Beyond Cancer Publishes Pre-Clinical Data in Cells Demonstrating that the Combination of Ultra-High Concentration Nitric Oxide and Anti-mPD-1 Therapy Improves Tumor Regression Rates and Survival in Mice
| XAIR Stock | USD 0.47 0.01 1.06% |
Slightly above 53% of Beyond Air's investor base is interested to short. The analysis of overall sentiment of trading Beyond Air stock suggests that many investors are impartial at this time. Beyond Air's investing sentiment overview a quick insight into current market opportunities from investing in Beyond Air. Many technical investors use Beyond Air stock news signals to limit their universe of possible portfolio assets and to time the market correctly.
Beyond |
Figure 1 PD-L1 Upregulation in CT26 and 4T1 Cells after In Vitro Exposure to UNO Figure 2 T-cell profiling in tumors of CT26 mice treated with UNO Figure 3 Myeloid cell profiling in CT26 tumors treated with UNO UNO therapy results in a more immunogenic tumor microenvironment as well as a systemic response that overcomes anti-PD-1 resistance First-in-human Phase 1 clinical study is ongoing with initial data expected to be released on November 3rd at the Society for Immunotherapy of Cancer
Read at finance.yahoo.com
 |
Beyond Air Investor Sentiment by Other News Outlets
Investor sentiment, mood or attitude towards Beyond Air can have a significant impact on its stock price or the market as a whole. This sentiment can be positive or negative, and various factors, such as economic indicators, news events, or market trends, can influence it. When investor sentiment is positive, investors are more likely to buy stocks, increasing demand and increasing the stock price. Positive investor sentiment can be driven by good news about the company or the broader market, such as solid earnings reports or positive economic data.
Note that negative investor sentiment can cause investors to sell stocks, leading to a decrease in demand and a drop in the stock price. Negative sentiment can be driven by factors such as poor earnings reports, negative news about the company or industry, or broader economic concerns. It's important to note that investor sentiment is just one of many factors that can affect stock prices. Other factors, such as company performance, industry trends, and global economic conditions, can also play a significant role in determining the value of a stock.
Beyond Air Fundamental Analysis
We analyze Beyond Air's financials across various querterly and yearly statements, indicators and fundamental ratios. We help investors to determine the real value of Beyond Air using virtually all public information available. We use both quantitative as well as qualitative analysis to arrive at the intrinsic value of Beyond Air based on its fundamental data. In general, a quantitative approach, as applied to this company, focuses on analyzing financial statements comparatively, whereas a qaualitative method uses data that is important to a company's growth but cannot be measured and presented in a numerical way.
Total Debt
Total Debt Comparative Analysis
Beyond Air is currently under evaluation in total debt category among its peers. Total Debt refers to the amount of long term interest-bearing liabilities that a company carries on its balance sheet. That may include bonds sold to the public, notes written to banks or capital leases. Typically, debt can help a company magnify its earnings, but the burden of interest and principal payments will eventually prevent the firm from borrow excessively.
Beyond Air Potential Pair-trading
One of the popular trading techniques among algorithmic traders is to use market-neutral strategies where every trade hedges away some risk. Because there are two separate transactions required, even if one position performs unexpectedly, the other equity can make up some of the losses. Below are some of the equities that can be combined with Beyond Air stock to make a market-neutral strategy. Peer analysis of Beyond Air could also be used in its relative valuation, which is a method of valuing Beyond Air by comparing valuation metrics with similar companies.
Peers
Beyond Air Related Equities
| DCTH | Delcath Systems | 2.63 | ||||
| LUCD | Lucid Diagnostics | 2.60 | ||||
| NPCE | Neuropace | 1.10 | ||||
| KIDS | Orthopediatrics Corp | 0.91 | ||||
| LUNG | Pulmonx Corp | 0.00 | ||||
| NARI | Inari Medical | 1.35 | ||||
| ELMD | Electromed | 1.47 | ||||
| TMCI | Treace Medical | 1.70 | ||||
| TMDX | TransMedics | 2.21 | ||||
| TELA | Tela Bio | 2.46 | ||||
| SGHT | Sight Sciences | 3.76 | ||||
| CTKB | Cytek Biosciences | 4.02 | ||||
| CVRX | CVRx | 4.25 | ||||
| RCEL | Avita Medical | 4.68 | ||||
| CLPT | Clearpoint Neuro | 6.52 |
Additional Tools for Beyond Stock Analysis
When running Beyond Air's price analysis, check to measure Beyond Air's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Beyond Air is operating at the current time. Most of Beyond Air's value examination focuses on studying past and present price action to predict the probability of Beyond Air's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Beyond Air's price. Additionally, you may evaluate how the addition of Beyond Air to your portfolios can decrease your overall portfolio volatility.